Clinical Trial Detail

NCT ID NCT03967093
Title A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bexion Pharmaceuticals, Inc.
Indications

brain cancer

atypical teratoid rhabdoid tumor

embryonal cancer

Advanced Solid Tumor

Therapies

BXQ-350

Age Groups: adult child

No variant requirements are available.